Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients

Author:            

Publisher: Science Publishers

ISSN: 2049-9450

Source: Molecular and Clinical Oncology, Vol.3, Iss.6, 2015-01, pp. : 1295-1300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content